Program Information

Pediatric Treatment Planning II: The PENTEC Report On Normal Tissue Complications

L Constine

D Hodgson

S Bentzen

L Constine¹*, D Hodgson²*, S Bentzen³*, (1) (2) (3) University of Maryland, Baltimore, MD

Presentations

MO-D-BRF-1 Monday 11:15AM - 12:15PM Room: Ballroom F

With advances in multimodality therapy, childhood cancer cure rates approach 80%. However, both radiotherapy and chemotherapy may cause debilitating or even fatal 'late effects' that are critical to understand, mitigate, or prevent. QUANTEC identified the uncertainties relating to side-effects of adult treatments, but this is more complicated for children in whom a mosaic of tissues develops at different rates and temporal sequences. Childhood cancer survivors have long life expectancy and may develop treatment-induced secondary cancers and severe organ/tissue injury decades after treatment. Collaborative long-term observational studies and clinical research programs for survivors of pediatric and adolescent cancer provide some dose-response data for follow-up periods exceeding 40 years. Data analysis is challenging due to the influence of both therapeutic and developmental variables. PENTEC is a group of radiation oncologists, pediatric oncologists, subsepcialty physicians, medical physicists, biomathematic modelers/statisticians, and epidemiologists charged with conducting a critical synthesis of existing literature aiming to: critically analyze radiation dose-volume effects on normal tissue tolerances as a function of age/development in pediatric cancer patients in order to inform treatment planning and improve outcomes for survivors; describe relevant physics issues specific to pediatric radiotherapy; propose dose-volume-outcome reporting standards to improve the knowledge base to inform future treatment guidelines. PENTEC has developed guidelines for systematic literature reviews, data extraction tolls and data analysis.

This education session will discuss:
1. Special considerations for normal tissue radiation response of children/adolescents, e.g. the interplay between development and radiotherapy effects.
2. Epidemiology of organ/tissue injuries and secondary cancers.
3. Exploration of dose-response differences between children and adults
4. Methodology for literature review, data mining of outcomes databases, and NTCP or longitudinal modeling of dose-response.
5. PENTEC goals and timetable.

Learning Objectives:
1. Understand important differences between normal tissue effects of radiation therapy in pediatric and adult patients.
2. Be able to identify situations where there is 'interplay' between organ development and radiation-induced complications.
3. Identify methods to systematically extract quantitative dose-volume-response relationships from existing outcomes databases.
4. Provide guidance for the medical physicist to properly understand, implement, guide and control contemporary technology and applications in pediatric radiation oncology.

Handouts

• 90-25491-334462-108362.pdf (L Constine)

• 90-25492-334462-108363.pdf (D Hodgson)

• 90-25493-334462-108364.pdf (S Bentzen)

Contact Email: